In other countries
The same active substances on other registers, the same brand first.
Authorised centrally in the EU
This national listing belongs to a medicine the European Commission authorised for the whole EU.
- Zebinix 50 MG/ML Suspension OralSpain · 50 mg · suspensión oral · Bial Portela & Ca S.A.Same brand
- Zebinix 200 MG ComprimidosSpain · 200 mg · comprimido · Bial Portela & Ca S.A.Same brand
- Zebinix 800 MG ComprimidosSpain · 800 mg · comprimido · Bial Portela & Ca S.A.Same brand
- ZebinixEuropean Union · BIAL - Portela & Ca, S.A.Same brand
- ZebinixCroatiaSame brand
- ZebinixItaly · Compressa · Bial -Portela & Ca ,SASame brand
- Apo-EslicarbazepineCanada · 800 MG · Tablet · Apotex INCSame substance
- Apo-EslicarbazepineCanada · 400 MG · Tablet · Apotex INCSame substance
- Apo-EslicarbazepineCanada · 600 MG · Tablet · Apotex INCSame substance
- ExaliefEuropean Union · BIAL - Portela Ca, S.A.Same substance
- ArupsanItaly · Compressa · Accord Healthcare, S.L.U.Same substance
- Eslicarbazepina Acetato AurobindoItaly · Compressa · Aurobindo Pharma (Italia) S.R.L.Same substance
- AptiomUnited States · 200MG, 400MG, 600MG … · tablet · Sumitomo Pharma AmSame substance
- Eslicarbazepine AcetateUnited States · 200MG, 400MG, 600MG … · tablet · LupinSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Eslicarbazepine
- Dosage form
- Suspensie voor oraal gebruik
- Route
- Oraal gebruik
- Register
- Netherlands (CBG-MEB)
- Status
- Authorised
- Status in the register
- Ingeschreven
- Authorised
- 8 Dec 2016
- Registration
- EU/1/09/514
- Marketing authorisation holder
- BIAL - Portela & C, S.A.
- ATC code
- N03AF04
- Group
- Nervous system
- Procedure
- EU centralised
- Supply
- Uitsluitend recept
- EMA product number
- EMEA/H/C/000988
- EU number
- EU/1/09/514